Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135,992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R, Fu D, Dong L, Zhang MC, Shi Q, Shi ZY, Cheng S, Wang L, Xu PP, Zhao WL. Shen R, et al. Among authors: wang l. Signal Transduct Target Ther. 2023 Apr 10;8(1):145. doi: 10.1038/s41392-023-01358-y. Signal Transduct Target Ther. 2023. PMID: 37032379 Free PMC article.
Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma.
Qin W, Wang N, Shi Q, Sun R, Zheng Z, Fu D, Dong L, Li C, Zhang Y, Xu P, Cheng S, Qian Y, Feng Y, Wang L, Zhao W. Qin W, et al. Among authors: wang l, wang n. Clin Transl Med. 2023 Jun;13(6):e1293. doi: 10.1002/ctm2.1293. Clin Transl Med. 2023. PMID: 37288581 Free PMC article. No abstract available.
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
Xiong J, Dai YT, Wang WF, Zhang H, Wang CF, Yin T, Cheng S, Zhong HJ, Yu SH, Jiang L, Wang SY, Fang H, Zhang RH, Zhu Y, Yi HM, Jiang XF, Chen JY, Wang L, Xu PP, Chen SJ, Zhao WL. Xiong J, et al. Among authors: wang l, wang wf, wang cf, wang sy. Sci Bull (Beijing). 2023 Nov 15;68(21):2607-2619. doi: 10.1016/j.scib.2023.09.029. Epub 2023 Sep 22. Sci Bull (Beijing). 2023. PMID: 37798178 Free article.
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
Xiong J, Cheng S, Gao X, Yu SH, Dai YT, Huang XY, Zhong HJ, Wang CF, Yi HM, Zhang H, Cao WG, Li R, Tang W, Zhao Y, Xu PP, Wang L, Zhao WL. Xiong J, et al. Among authors: wang l, wang cf. Signal Transduct Target Ther. 2024 Mar 6;9(1):62. doi: 10.1038/s41392-024-01782-8. Signal Transduct Target Ther. 2024. PMID: 38448403 Free PMC article. Clinical Trial.
135,992 results
You have reached the last available page of results. Please see the User Guide for more information.